COMPUTATIONAL STUDY OF ANTIDIABETIC ACTIVITIES OF BIOACTIVE COMPOUNDS IN ZINGIBER OFFICINALE
*Ly Le
ABSTRACT
Herbal, especially Zingiberofficinale,has been reported as a source of
potential medication for diabetes type 2 treatment. Even
thoughZingiberofficinale function in diabetes treating was well
published, there has been a lack of studies indicating association of its
bioactive compounds with agents involving in diabetes. This study
aims to research on the activity of certain bioactive compounds in
Zingiberofficinale. In the other words, a research was conductedby a
variety of computational interactions utilizing Molecular Docking and
Pharmacophore between ginger compounds: 4-gingerol, 6-gingerol, 8-
gingerol, 10-gingerol, 6-shogaol and β-Bisabolol and target proteins: :
Glutamine fructose-6-phosphate aminotransferase (GFAT), SIRT6 (Sirtuin-6), GLUT4
(Glucose transporter type 4), 11β-hydroxysteroid dehydrogenase type 1 and Glycogen
phosphorylase so as to observe hydrophobic interaction, hydrogen bonds. Indeed, they play a
crucial role in stabilizing energetically favored ligands, in an open conformational
environment of protein structures. In addition, Lipinski’s Rule was applied for selecting
potential ligands as candidates for produce diabetes type 2 drug supporting further analysis
on anti-diabetic agents ofZingiberofficinale. As a result, it can be claimed that
Zingiberofficinale containing a variety of bioactive compounds that have been functional
effects for diabetes type 2 treating therapy.
Keywords: Zingiber officinale, diabetes, receptor, proteins, bioactive compounds, GFAT, GLUT4, Glycogenphosphate, SIRT6, 11?-HSD1, affinity, pharmacophore, docking.
[Download Article]
[Download Certifiate]